| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $228.4M | -0.9% |
| Cost of Revenue | $58.2M | -9.7% |
| R&D Expense | $62.1M | +13.0% |
| SG&A Expense | $70.8M | -11.6% |
| Operating Income | $37.3M | +20.5% |
| Pre-tax Income | $35.8M | +48.5% |
| Income Tax | $4.7M | +175.6% |
| Net Income | $31.1M | +2.8% |
| EPS (Basic) | $0.62 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $29.6M | -57.2% |
| Short-term Investments | $67.9M | +113.9% |
| Accounts Receivable | $53.7M | +67.6% |
| Inventory | $5.5M | -36.8% |
| Current Assets | $162.7M | +10.2% |
| Total Assets | $216.3M | +1.4% |
| Current Liabilities | $81.3M | -15.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $41.8M | +7.4% |
| Capital Expenditures | $71K | +26.8% |
| Investing Cash Flow | -$36.2M | -77.1% |
| Financing Cash Flow | -$45.2M | -33.5% |
| Free Cash Flow | $41.7M | +7.4% |
| +0.0% |
| EPS (Diluted) | $0.61 | -1.6% |
| Long-term Debt |
| $22.7M |
| -66.7% |
| Total Liabilities | $86.0M | -29.1% |
| Stockholders' Equity | $130.3M | +41.5% |